HER2 as a potential therapeutic target on quiescent prostate cancer cells.

ABSTRACT: Quiescent prostate cancer (PCa) cells are common in tumors but are often resistant to chemotherapy. Quiescent PCa cells are also enriched for a stem-like tumor initiating population, and can lead to recurrence after dormancy. Unfortunately, quiescent PCa cells are difficult to identify and / or target with treatment in part because the relevant markers are intracellular and regulated by protein stability. We addressed this problem by utilizing PCa cells expressing fluorescent markers for CDKN1B (p27) and CDT1, which can separate viable PCa cells into G₀, G₁, or combined S/G₂/M populations. We used FACS to collect G₁ and G₀ PC3 PCa cells, isolated membrane proteins, and analyzed protein abundance in G₀ vs G₁ cells

SUBMITTER: Yumoto K 

PROVIDER: S-EPMC9971552 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature